In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alti-Triazolam Drug Master File in Korea (Alti-Triazolam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alti-Triazolam. The MFDS reviews the Alti-Triazolam KDMF as part of the drug registration process and uses the information provided in the Alti-Triazolam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alti-Triazolam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alti-Triazolam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alti-Triazolam suppliers with KDMF on PharmaCompass.